Radiation Oncology Department, Fundacion Instituto Valenciano de Oncologia (I.V.O.), C/Profesor Beltran Baguena 8, 46009, Valencia, Spain.
Radiation Oncology Department, Hospital Clinico Universitario de Valladolid, Valladolid, Spain.
Clin Transl Oncol. 2024 Feb;26(2):456-460. doi: 10.1007/s12094-023-03265-8. Epub 2023 Aug 7.
Brachytherapy (BT) has been used for many years for disease control in tumours of the head and neck area (H&N). It is currently performed with high dose rate (HDR) or pulsed dose rate (PDR), but its use has been reduced due to the implementation of new non-invasive external beam radiotherapy techniques such as intensity modulation (IMRT) and volumetric modulated arc therapy (VMAT) and the improvement of surgical techniques.
The Spanish Brachytherapy Group (GEB) has carried out a survey to find out the number of centres in Spain that continue to use BT in H&N and its indications and expectations for the future.
The results were presented at the XX GEB Consensus Meeting held on October 21, 2022, in Valencia (Spain) and it was confirmed that, although there are fewer and fewer centres that use BT in H&N, there are still units with extensive experience in this technique that should be positioned as referral centres.
It is necessary to carry out continuous work with other specialities involved, such as H&N surgeons, and other radiation oncologists, to improve the training of residents, both oncologists and medical physicists.
近距离放射治疗（BT）已在头颈部（H&N）肿瘤的疾病控制中使用多年。目前使用高剂量率（HDR）或脉冲剂量率（PDR）进行治疗，但由于新的非侵入性外部射束放射治疗技术（如调强放射治疗（IMRT）和容积调强弧形治疗（VMAT））的实施以及手术技术的改进，其使用已减少。
西班牙近距离放射治疗组（GEB）进行了一项调查，以了解西班牙继续在 H&N 中使用 BT 及其适应症和未来预期的中心数量。
这些结果于 2022 年 10 月 21 日在西班牙巴伦西亚举行的第 XX 次 GEB 共识会议上提出，证实尽管在 H&N 中使用 BT 的中心越来越少，但仍有一些单位在该技术方面拥有丰富的经验，应定位为转诊中心。
有必要与涉及的其他专业（如头颈部外科医生和其他放射肿瘤学家）进行持续的工作，以提高住院医师（肿瘤学家和医学物理学家）的培训水平。
